Risk of new vertebral fracture in the year following a fracture.
By R. Lindsay, S. Silverman, Chris Cooper, D. Hanley, I. Barton, S. Broy, A. Licata, L. Benhamou, P. Geusens, Kirsten Flowers and 2 more. Journal of the American Medical Association (JAMA), 2001
1,859 citations recorded by the source corpus.
Subfields: Orthopedics and Sports Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/7db1477a8a59fc05dbc9a579e9da771fa7232f1f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Orthopedics and Sports Medicine
In Surgery
Citations in the corpus
- A meta-analysis of previous fracture and subsequent fracture risk. (2004, background): “higher in patients with a prior vertebral deformity than in those without [4,25,26].”
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. (2019, background): “(1-84), romosozumab, strontium ranelate, and lasofoxifene (Fig.”
- Osteoporosis in the European Union: medical management, epidemiology and economic burden (2013, background): “Summary and key messages 5.1 Uptake of osteoporosis treatment 5.2 Data and methods 5.3 Pharmacological treatment 5.4 Market shares 5.5 Population coverage 5.6 Uptake of individual treatments 5.6.1 Alendronate 5.6.2 Denosumab 5.6.3 Etidronate 5.6.4 Ibandronate 5.6.5 PTH (1-84) 5.6.6 Raloxifene 5.6.7 ”
- Epidemiology, etiology, and diagnosis of osteoporosis. (2006, background): “Moreover, it has been shown that in women who have an incident vertebral fracture develop, 1 in 5 have a new vertebral fracture develop in the subsequent year.(34) Impaired vision (ie, poor depth perception and reduced ability to perceive contrast) independently increases the risk of hip fracture in”
- Skeletal remodeling in health and disease (2007, background): “Even though their mechanisms are not fully understood, most bisphosphonates produce robust reductions in fracture risk, often within one year, by stabilizing trabecular connectivit”
- 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary (2010, background): “Such fractures are associated with a five-fold increase in the risk of future vertebral fractures relative to those without vertebral fractures.(17)”
- Underdiagnosis of Vertebral Fractures Is a Worldwide Problem: The IMPACT Study (2004, background): “Discrepancy rates were performed for the entire study group and by prospectively defined geographic regions: (1) Europe/South Africa/Australia; (2) North America; and (3) Latin America.”
- Osteoporosis: a still increasing prevalence. (2005, background): “In one assessment of 4356 subjects from 4 large clinical trials, 20% of patients experienced a second fracture within the first year [22].”
- Vertebroplasty and Kyphoplasty: A Systematic Review of 69 Clinical Studies (2006, background): “6%), even among those studies that did not attain an average 1-year follow-up (Figure 5).(49,104) However, whether there is any difference between fracture rates after the procedure and those within a general osteoporotic population that has had a previous vertebral fracture (19%(104)) cannot be con”
- The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group (2014, background): “An incident vertebral fracture strongly predicts an increased risk of another vertebral fracture as soon as within the next year [9].”